GEODE CAPITAL MANAGEMENT, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 38 filers reported holding XENON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,911,081
-11.2%
55,945
+0.1%
0.00%
Q2 2023$2,152,727
+7.9%
55,915
+0.3%
0.00%
Q1 2023$1,994,397
+91428.1%
55,725
+0.8%
0.00%
Q4 2022$2,179
-99.9%
55,285
-10.6%
0.00%
Q3 2022$2,231,000
+61.2%
61,823
+35.8%
0.00%
Q2 2022$1,384,000
+60.6%
45,516
+61.4%
0.00%
Q1 2022$862,000
-2.0%
28,1980.0%0.00%
Q4 2021$880,000
+166.7%
28,198
+30.2%
0.00%
Q3 2021$330,000
-18.1%
21,6500.0%0.00%
Q2 2021$403,000
+17.2%
21,650
+12.5%
0.00%
Q1 2021$344,000
+16.6%
19,2420.0%0.00%
Q4 2020$295,000
+38.5%
19,2420.0%0.00%
Q3 2020$213,000
-11.6%
19,2420.0%0.00%
Q2 2020$241,000
+10.6%
19,2420.0%0.00%
Q1 2020$218,000
-56.7%
19,242
-50.0%
0.00%
Q4 2019$504,000
+191.3%
38,484
+100.0%
0.00%
Q3 2019$173,000
-8.5%
19,2420.0%0.00%
Q2 2019$189,000
+32.2%
19,242
+36.6%
0.00%
Q1 2019$143,000
-18.8%
14,084
-50.0%
0.00%
Q4 2018$176,000
+329.3%
28,168
+171.2%
0.00%
Q1 2017$41,000
-46.8%
10,386
+3.7%
0.00%
Q4 2016$77,00010,0200.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,594,932$48,518,00010.26%
GREAT POINT PARTNERS LLC 1,104,334$33,594,0008.06%
ACUTA CAPITAL PARTNERS, LLC 272,500$8,289,0004.62%
DAFNA Capital Management LLC 438,623$13,343,0003.64%
Parkman Healthcare Partners LLC 294,559$8,960,0003.30%
Avoro Capital Advisors LLC 4,900,000$149,058,0002.94%
Nan Fung Group Holdings Ltd 114,380$3,479,0002.39%
BVF INC/IL 1,597,966$48,610,0002.35%
SILVERARC CAPITAL MANAGEMENT, LLC 232,630$7,077,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,391,038$133,575,0002.16%
View complete list of XENON PHARMACEUTICALS INC shareholders